Claritev Corp. (CTEV)
41.14
+0.03
(+0.07%)
USD |
NYSE |
Dec 19, 16:00
40.45
-0.69
(-1.68%)
After-Hours: 20:00
Claritev EPS Diluted (Quarterly): -4.232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spok Holdings, Inc. | 0.1523 |
| DarioHealth Corp. | -3.052 |
| National Research Corp. | 0.1805 |
| Axe Compute, Inc. | -107.25 |
| GoodRx Holdings, Inc. | 0.0032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.75M |
| Revenue (Quarterly) | 245.96M |
| Total Expenses (Quarterly) | 315.71M |
| Enterprise Value | 5.281B |
| Gross Profit Margin (Quarterly) | 29.26% |
| Profit Margin (Quarterly) | -28.36% |
| Earnings Yield | -50.91% |
| Operating Earnings Yield | 7.55% |
| Normalized Earnings Yield | -37.44 |